Each week we highlight five things affecting the life sciences industry. Here’s the latest. … READ MORE >
pharmaceuticals
5 things to know in life sciences: Week of Oct. 16, 2023
Each week we highlight five things affecting the life sciences industry. Here’s the latest. … READ MORE >
5 things to know in life sciences: Week of November 15
From a new virtual reality system to treat chronic back pain to sustainable pharmaceuticals, each week we highlight five things impacting the life sciences industry. … READ MORE >
CHART OF THE DAY: FTC challenges biopharma merger as antitrust scrutiny grows
Less than two weeks after the Federal Trade Commission announced it would be taking a more stringent look at mergers in the biopharmaceutical industry, the proposed Illumina and Grail merger became only the second vertical merger in 40 years to be legally challenged by the agency. … READ MORE >
5 things to know in life sciences: Week of March 15
This week we highlight possible heightened scrutiny related to pharma mergers, top drugs losing their exclusivity this year, artificial intelligence-powered hearing aids and more. … READ MORE >
5 things to know in life sciences: Week of March 1
In this week’s roundup we look at new data coming out of the U.K. and Israel on their COVID-19 vaccination programs’ results. We also highlight improvements in public perception of the pharmaceutical industry, a new executive order on supply chains and more. … READ MORE >
5 things to know in life sciences: Week of Jan. 25
This week’s roundup includes reads about a crucial shift in the life sciences ecosystem; the interplay between the digital future of life science, the development of next generation therapeutics, and the promise of personalized medicine. We also take a look at news about COVID-19 variants and drug pricing. … READ MORE >
5 things to know this week in life sciences: Week of Jan. 11
News this week included Bluebird Bio’s announcement about splitting into two companies, the promise of quantum computing in drug design, and how mRNA platforms offer promise for diseases beyond COVID-19. … READ MORE >
5 things to know this week in life sciences: Week of Jan. 4
In this week’s industry roundup, we look at recent drug price increases, the ongoing battle over 340B program discounts, key catalysts in Q1 for middle market biotech companies, and more. … READ MORE >
5 things to know this week in life sciences: Week of Dec. 21
With approval of Moderna’s COVID-19 vaccine last week for emergency use, many of us are looking forward to getting vaccinated. But this is also a good time to reflect on the decades of work that laid the groundwork for this lightning fast vaccine development effort. … READ MORE >